S&P 5007,713▲ 0.28%Nasdaq26,425▼ 0.02%Dow Jones52,496▲ 1.02%Nasdaq 10029,490▼ 0.13%VIX17.31▼ 6.13%US Dollar101.73▼ 0.25%Gold spot4,145▲ 0.30%WTI spot101.91▲ 1.04%
Home › PXA › Research report
← PXA page
XStocksXray
Market X-Ray report · 20 October 2026

Pexa Group Ltd (PXA)

Australian Securities Exchange · Australia · prices in AUD · close of 20 Oct 2026

Key indicators

Last closeAUD 6.550
52-week range6.150 – 16.050
Return, 1 month / 3 months−6.4% / −12.1%
Return, 1 year / 3 years−57.6% / −39.9%
TrendBelow its 200-day average
RSI (14)47
Volatility (1 year)46.5%
Worst drawdown (1 year)-61.1%
Average daily value traded4.69M AUD
Dividend yield–

Market X-Ray price-based

41/ 100 · High confidence · ahead of 38% of stocks on this exchange
Trend18
Momentum23
Stability (higher is calmer)55
Liquidity87
Income–

Five-year price chart navy: price · brown: 200-day average

5.359.3113.2817.2421.202021-102023-012024-042025-072026-10

About the company

Pexa Group operates an electronic platform for property transactions, allowing lawyers, conveyancers, banks and lenders to complete property settlements and lodgement of land titles digitally rather than on paper. The company is based in Australia and its core network connects financial institutions, legal practitioners and government land registries. It also provides related services around property data and has extended its conveyancing technology into the United Kingdom market.

Pexa Group Ltd trades under the code PXA on the Australian Securities Exchange in Australia, with its price quoted in Australian dollars (AUD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Pexa Group Ltd (PXA) trades on the Australian Securities Exchange in Australia. It last closed at AUD 6.550 on 20 October 2026.

Its price-based Market X-Ray is 41 out of 100 (a weak price profile), ranking 1,134 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 57.6% and over the last three months it fell 12.1%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Pexa Group Ltd (PXA)

The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange

Lens and metricValueScoreReading
Trend18 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-39.2%
From 52-week high-58.9%
Momentum23 · WeakLagging most stocks on this exchange.
3-month return-12.1%
6-month return-47.0%
12-month return, skipping the last month-54.7%
Stability (higher is calmer)55 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)46.5%
Worst drawdown, 1 year (smaller is calmer)-61.1%
Liquidity87 · StrongTrades actively.
Average daily value traded4.69M AUD
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Liquidity: Trades actively.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.

Returns

1 week+4.0%
1 month−6.4%
3 months−12.1%
6 months−47.0%
1 year−57.6%
3 years−39.9%
5 years−58.4%

Signals

50-day / 200-day average7.047 / 10.776
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceYes
Average daily range (ATR)0.221

Technical summary

DailyBearish4 bullish · 4 neutral · 8 bearish
WeeklyStrongly bearish0 bullish · 1 neutral · 11 bearish
MonthlyStrongly bearish1 bullish · 0 neutral · 7 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 21 Oct 2026